Efficacy of High-dose Intravenous Immunoglobulin Therapy for Hyperbilirubinemia Due Rh Hemolytic Disease

NCT00288600 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
92
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Oswaldo Cruz Foundation

Collaborators